By type of agonist the market is single-agonist, dual-agonist and tri-agonist, by route of administration market is categorized into oral and parenteral, by target indication market is categorized into Alzheimers disease, non-alcoholic steatohepatitis, obesity, sleep apnea, type 2 diabetes
Patients with severe gastrointestinal diseases such as gastroparesis and inflammatory bowel disease should avoid GLP-1 analogs, and these medications are not recommended for patients with certain genetic predispositions
10.1016/S0140-6736(98)11058-9 29
Who May Be at Greater Risk of Joint-Related Symptoms Patients with pre-existing arthritis, obesity-related joint loading, or older age are at greater baseline risk
10.3390/molecules27196377 Summary Keywords natural products, mitochondrial dysfunction, energy metabolism, kidney diseases, mitochondrial homeostasis Citation Huang J, Liang Y and Zhou L (2023) Natural products for kidney disease treatment: Focus on targeting mitochondrial dysfunction
Patients often report lowered cardiovascular risk, improved blood sugar control, and enhanced general well-being
